On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Cory Firth, the Co-Founder of Neuma. On his LinkedIn profile, Cory...
Booty bumping may sound like a fun way to party, but boofing ketamine comes with some hefty risks.
The founder of TOMS has taken interest, too. The post Tara Mind attracts $8M to bring ketamine therapy to workplace benefits appeared first on Green Market...
Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing medication-assisted treatments...
Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing medication-assisted treatments...
The study will focus on treatment for four medical conditions. The post EU awards €6.5 million for psychedelic drug trial appeared first on Green Market...
Tissue engineering, which involves the use of grafts or scaffolds to aid cell regeneration, is emerging as a key medical practice for treating volumetric...
Explore the world of Kanna in our comprehensive guide. Discover its unique benefits for mental, emotional, and physical health, and what brand we reco...
Toronto, Ontario–(Newsfile Corp. – January 23, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or...
Toronto, Ontario–(Newsfile Corp. – January 23, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or...
–Recently announced positive Phase 1 topline safety, pharmacokinetic (“PK”) and pharmacodynamic (“PD”) data show that intravenous (“IV”)...
Passage of federal legislation would allow the company to process credit cards for transactions on its app. The post Uber continues U.S. cannabis lobbying...
Listing fees linked to the recent reverse takeover were significant. The post Safe Supply Posts Q4 Uplisting Costs Ahead of New Game Plan appeared first...
Cybin Inc. (NYSE: CYBN) announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for CYB004,...
2023— the year that everyone in the psychedelic industry prepared for takeoff. Well, theoretical (but probable) take off. And, just a few weeks before...